Clinical trial
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating…
NCT00005792 · H. Lee Moffitt Cancer Center and Research Institute, Other · Completed
Key facts
| NCT number | NCT00005792 |
|---|---|
| Title | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma |
| Official title | A Study of Intensive-Dose Melphalan, Topotecan, and VP-16 Phosphate (MTV) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Collaborators | SmithKline Beecham Industry Bristol-Myers Squibb |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Plasma Cell Neoplasm |
| Intervention type | Drug, Procedure |
| Interventions | etoposide phosphate, melphalan, topotecan, Autologous Stem Cell Rescue |
| Enrollment | 131 |
| Start date | Jun 2, 1998 |
| Primary completion | Jul 1, 2006 |
| Completion | Nov 1, 2018 |
| First posted | Feb 2, 2004 |
| Last update posted | Nov 8, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: